news about tirzepatide Weight-loss jab Mounjaro trial begins in Manchester FDA confirms tirzepatide shortage is

A network meta-analysis of the comparative efficacy of different dietary approaches on glycaemic control and weight loss in patients with type 2 diabetes mellitus and overweight or obesity

As UK scientific research continues to unveil the transformative potential of peptide therapy, the future of longevity and vitality looks increasingly promising

LM: Methodology, Visualization, Writing original draft

Mounjaro is approved for type 2 diabetes management and Zepbound is approved for chronic weight management in adults with obesity or overweight with a weight-related condition

Those who relied primarily on the medication without lifestyle modifications face higher risks of regaining weight

10.1523/JNEUROSCI.4920-04.2005 J